Full text is available at the source.
Combined anti-inflammatory effects of gut bacteria and lithocholic acid on liver scarring
Updated
Abstract
Lithocholic acid (LCA) inhibited the activation of hepatic stellate cells (HSCs) through apoptosis and modulation of specific signaling pathways.
- LCA may reduce the activation of TGF-β signaling pathways associated with liver fibrosis.
- LCA is linked to enhanced differentiation of macrophages into an anti-inflammatory M2 type while inhibiting the pro-inflammatory M1 type.
- The recruitment of natural killer (NK) cells increased with LCA treatment, alongside a reduction in the activation of NKT cells.
- The beneficial effects of LCA were diminished when antibiotics were used, which lowered the diversity and abundance of gut microbiota.
- Gut microbiota and LCA may work together to provide anti-inflammatory effects in liver fibrosis.
Simplified